| Literature DB >> 23497464 |
Abstract
Over the last half century there has been an epidemic of diminished health status induced by what seems as a concurrent rise in a population of individuals that are overfat. During the past few decades, the use of exercise has become a staple in the prevention and treatment options for the retarding the development of health issues pertaining to individuals who are overweight, overfatness or experience obesity. However, there are few studies and reviews look at the global issues surrounding the metabolic and hormone consequences of overfatness and the interaction of exercise with adiposity in humans developing the health status for the individual. This review offers an insight into our current understanding of health issues pertaining to metabolic and hormonal disruption related to overfatness and the treatment effect that exercise, especially resistance exercise, can have on impacting the health status, and overall well-being, for individuals who are overfat, regardless of body compositional changes leading toward a lessening of diseased state, and eventually a return to a normal health status for the individual.Entities:
Year: 2012 PMID: 23497464 PMCID: PMC3602007 DOI: 10.1186/2251-6581-11-19
Source DB: PubMed Journal: J Diabetes Metab Disord ISSN: 2251-6581
Figure 1The interrelationship between the various physiological and societal factors, that influence the development of the health behaviors for the individual that in turn impact the overall body morphology and eventual levels of overall health for any individual, regardless of level of adiposity (overfatness) or recognition of obesity.
Figure 2Societal (combination of the familial and environment) factors that contribute the formation of the health behaviors that impact the development of body morphology, e.g., accumulation of fat or fat-free mass, and various factors of fitness which interact to comprise the overall health status for any individual.
Figure 3Physiological (Genetic and Hormonal) factors that influence on cell physiology and the impact of cell physiology that contribute the formation of the fitness for the individual along with the development of body morphology, e.g., accumulation of fat or fat-free mass, which interact to comprise the overall health status for any individual.
Figure 4Interaction between the factors of fitness and fatness the form an inverse relationship combining to eventually determine the overall health status for the individual, while the factors and components are identified as individual markers there is actually a highly elaborate web-like interaction between the various factors and is based on the premise of an inverse relationships between Total Fitness and Total Fatness where a high Total Fitness leads to improved overall health status (e. g., low disease state) and High Total Fatness leads to a diminished overall health status (e. g., high disease state).
Figure 5Outline of the factors that act as components of health behaviors influencing the various factors of fitness and fatness determining the Total Fatness and Total Fitness of the individual and therefore the overall health status for an individual. LEGENED: % CHO:amount of carbohydrates in diet, % Fat: amount of fat in diet, % Protein: amount of protein in diet.
Figure 6Examination of the continuum of the levels of fatness and fitness as they relate to an increase or decrease of relative risk for a diseased status for the individual’s health status regardless of observed level of adiposity. With each increase in level of physical activity, there appears to be an additive improvement to the reduction in the risk for disease state even with expression of high fatness. Note for fitness continuum* the more sedentary a person is they will perform only the minimal activities beyond those of daily living where as Inactive people only perform those activities of daily living. ** the difference between Active and Highly Active is # of day/week of activity.
Figure 7Interaction between increased caloric balance, reduced physical activity and exercise, increasing age, and/or increased level of psychosomatic stress on the hormonal influences for the development of hyper adiposity (i.e. over fatness and obesity) with reduction in lean body tissue and the subsequent downstream regulatory issues at the various tissues of body (e. g., adipocytes, skeletal muscle and liver) causing changes in production and secretion of deleterious cytokines, interleukins and adipokines that provides the basis for the eventual development of symptoms of metabolic syndrome and cardiovascular disease. Note that the reduced anabolic hormones (e.g., growth hormone, testosterone, Thyroid hormones, IGF) in production, release and response at the peripheral tissues and increased hypothalamic-pituitary-adrenal output (e.g. increased Epi/Norepi and Cortisol) leads to the downstream issues in series with the increase in visceral fatness from the simple increase in caloric balance (i.e. high dietary intake and low caloric expenditure).
Summary of the key Adipokine/Cytokine associated with health related issues of over-fatness and obesity
| Adiponectin [ | A | Skeletal Muscle (↑insulin sensitivity, ↓response to IL-6, TNF-α) | ↓ | ↑ |
| Liver (↑ insulin sensitivity, ↓response to IL-6, TNF-α) | ||||
| Adipocytes (↑insulin sensitivity, ↓response to IL-6, TNF-α) | ||||
| Cardiovascular Endothelial Cells (↓adhesion formation, ↓response to IL-6, TNF-α) | ||||
| Visfatin [ | A | Adipocytes (differentiation of cells) | ↑ | ↓/↔ |
| Skeletal Muscle (↑ insulin sensitivity) | ||||
| Liver (↑ insulin sensitivity) | ||||
| Leptin [ | A | Cardiovascular Endothelial Cells (↑ adhesion formation, ↑ response to IL-6, TNF-α) | ↑ | ↓ |
| Adipocytes (↑ production and release IL-6, TNF-α) | ||||
| Skeletal Muscle (↑insulin sensitivity, ↑ lipid metabolism, ↓response to IL-6, TNF-α) | ||||
| Hypothalamus/Central Nervous | ||||
| System (satiety, hunger response, indication of energy expenditure) | ||||
| Resistin [ | A, M | Cardiovascular Endothelial Cells (↑ adhesion formation)* | ↑ | ↓/↔ |
| Retinol Binding Protein-4 (RBP-4) [ | A | Skeletal Muscle (↓insulin sensitivity) | ↑ | ↓ |
| Liver (↓insulin sensitivity) | ||||
| Tumor Necrosis Factor-α (TNF-α) [ | A/M | Cardiovascular Endothelial Cells (↑ adhesion formation) | ↑ | ↓ |
| Skeletal Muscle (↓insulin sensitivity) | ||||
| Liver (↓insulin sensitivity) | ||||
| Interluekin-6 (IL-6) [ | M, A/M | Leukocytes (↑ activity and response) | ↑ | ↓ |
| Cardiovascular Endothelial Cells (↑ adhesion response) | ||||
| Skeletal Muscle (↓insulin sensitivity, ↑inflammation response w/in tissues) | ||||
| Liver (↓insulin sensitivity,↑inflammation response w/in tissues) | ||||
| Chemerin [ | A | Macrophage & Leukocyte (↑ activity and pro-inflammatory cytokine release) | ↑ | ? |
| Liver (↓insulin sensitivity,↑inflammation response w/in tissues) |
Note that * indicates that mixed results in outcome of results with research involving human volunteers,$ animal studies indicate impact on insulin sensitivity not duplicated with human subjects, A indicates adipose tissue derived chemical, M indicates macrophage derived chemical, A/M indicates both adipose tissue and macrophage derived chemical, ↑ indicates an increase in production and release, ↓indicates an decrease in production and release, ↔ indicates no effect in production and release, and ? indicates unknown response.
Hormones associated with the development and maintenance of lean body tissue and the impact of adiposity and exercise on the production and release by endocrine glands
| Testosterone/Adrenal Androgens [ | Testes Adrenal Cortex | Skeletal Muscle (hypertrophy, add contractile tissue) | ↓ with associated ↑ in SHBG | ↑ followed by ↓ | ↔, ↑,↓ |
| Bone (add bone mass) | |||||
| Adipose Tissue (break-down lipid) | |||||
| Growth Hormone [ | Anterior Pituitary Gland | Liver (generate IGF, gluconeogenesis, glycogenolysis) | ↓ with associated ↑ in GHBP | ↑ followed by ↓ | ↔, ↑,↓ |
| Skeletal Muscle (hypertrophy, add non-contractile tissue) | |||||
| Bone (add bone mass) | |||||
| Adipose Tissue (break-down lipid for use as fuel source) | |||||
| Insulin [ | Pancreas | Skeletal Muscle (glucose, amino acid, lipid uptake and storage) | ↑ (see Figure | ↑ during exercise bout, ↓following | ↓ |
| Liver (glucose uptake and storage) | |||||
| Adipose Tissue (glucose and lipid uptake and storage) | |||||
| Insulin-like Growth Factor (IGF) [ | Liver, Skeletal Muscle, Bone | Skeletal Muscle (hypertrophy, add non-contractile and contractile protein) | ↓ with associated ↑ in IGF-BP | ↑followed by ↓ | ↔, ↑,↓ |
| Bone (add bone mass) | |||||
| Cortisol [ | Adrenal Cortex | Skeletal Muscle (break-down of protein tissue, lipid break-down, decreased use of glucose) | ↑(see Figure | ↑ during exercise bout, ↓following | ↔,↓ |
| Bone (break-down of protein matrix) | |||||
| Liver (glycogenolysis) | |||||
| Adipose Tissue (break-down lipid for use as fuel source) | |||||
| Immune Cells (regulation of inflammatory response) | |||||
| Triiodothyronine (T3) [ | Thyroid | Skeletal Muscle (regulation of metabolism and fuel source utilization) | ↓ (Hypothyroidism associated with obesity unknown causal relationship) | ↑ during exercise bout, ↓following 60 minutes of recovery | ↔,↑ |
| Bone (regulation of generation of protein matrix) | |||||
| Adipose Tissue (regulation of lipid deposition and utilization) | |||||
| Thyroxin (T4) [ | Thyroid | Skeletal Muscle (regulation of metabolism and fuel source utilization) | ↓ (Hypothyroidism associated with obesity unknown causal relationship) | ↑ following exercise bout, ↓following 120 minutes of recovery | ↔,↑ |
| Bone (regulation of generation of protein matrix) | |||||
| Adipose Tissue (regulation of lipid deposition and utilization) |
Note that ↑ indicates an increase in production and release, ↓indicates a decrease in production and release, ↔ indicates no effect in production and release, and ? Indicates unknown response.
Figure 8Interaction between caloric restriction, increased physical activity and exercise, and a reduction in the level of psychosomatic stress on the hormonal influences for the reduction of hyperadiposity (i.e. overfatness and obesity) and increase in lean body tissue, leading to the improvement in subsequent downstream regulatory issues at the various tissues of body (e.g., adipocytes, skeletal muscle and liver) causing changes in production and secretion of deleterious cytokines, interleukins and adipokines that provides the basis for the eventual resolution of symptoms of metabolic syndrome and cardiovascular disease. Note that the improved response in anabolic hormones (e.g., growth hormone, testosterone, Thyroid hormones, IGF) in production, release and response at the peripheral tissues and decreased response at the hypothalamic-pituitary-adrenal axis (HPA) output (e.g. increased Epi/Norepi and Cortisol) leads to the resolution of previous downstream issues in series with the decrease in visceral fatness from the simple caloric restriction leading the resolution of overfatness, metabolic syndromes and cardiovascular disease. Note the ? on the Endurance Exercise pathway as mixed evidence indicates that increasing anabolic hormone release with Resistance Exercise is known while it is still in doubt as to the extent of changes following Endurance Exercise in regards to the release of anabolic hormones.